Your browser doesn't support javascript.
loading
HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy.
Joehlin-Price, Amy S; Komforti, Miglena K; Ladwig, Nicholas R; Devine, Patrick; Hoyle, Carrie; McCoy, Lauren; Sprague, Cathy; Astbury, Caroline; Hoda, Raza; Chen, Yunn-Yi; Garg, Karuna.
Afiliação
  • Joehlin-Price AS; Cleveland Clinic, Cleveland, OH.
  • Komforti MK; Mayo Clinic, Jacksonville, FL.
  • Ladwig NR; University of California, San Francisco, San Francisco, CA.
  • Devine P; University of California, San Francisco, San Francisco, CA.
  • Hoyle C; Cleveland Clinic, Cleveland, OH.
  • McCoy L; Cleveland Clinic, Cleveland, OH.
  • Sprague C; Cleveland Clinic, Cleveland, OH.
  • Astbury C; Cleveland Clinic, Cleveland, OH.
  • Hoda R; Cleveland Clinic, Cleveland, OH.
  • Chen YY; University of California, San Francisco, San Francisco, CA.
  • Garg K; Cleveland Clinic, Cleveland, OH.
Am J Surg Pathol ; 47(5): 580-588, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36939053
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Neoplasias da Mama / Cistadenocarcinoma Seroso / Carcinoma Endometrioide Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Am J Surg Pathol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Neoplasias da Mama / Cistadenocarcinoma Seroso / Carcinoma Endometrioide Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Am J Surg Pathol Ano de publicação: 2023 Tipo de documento: Article